Earnings
BIVI
1.270
+14.41%
0.160
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2025
0.00
--
--
--
--
18.07M
8.10M
9.27M
229.38K
--
468.00K
--
-18.07M
524.08K
--
--
-17.54M
--
-17.54M
--
--
--
-17.54M
--
-17.54M
-369.47K
-17.91M
-17.91M
--
-17.91M
1.48M
-12.12
-12.12
--
-11.81
FY 2024
0.00
--
--
--
--
32.18M
8.86M
23.10M
229.38K
--
-5220.00
--
-32.18M
59.05K
--
--
-32.12M
--
-32.12M
--
--
--
-32.12M
--
-32.12M
-886.42K
-33.01M
-33.01M
--
-33.01M
451.85K
-73.05
-73.05
--
-73.06
FY 2023
0.00
--
--
--
--
45.08M
11.55M
33.30M
229.38K
--
--
--
-45.08M
-5.18M
--
--
-50.26M
--
-50.26M
--
--
--
-50.26M
--
-50.26M
--
-50.26M
-50.26M
--
-50.26M
324.83K
-154.71
-154.71
--
-154.71
FY 2022
0.00
--
--
--
--
27.25M
9.77M
17.26M
229.38K
--
0.00
--
-27.25M
1.17M
--
--
-26.08M
--
-26.08M
--
--
--
-26.08M
--
-26.08M
0.00
-26.08M
-26.08M
--
-26.08M
246.63K
-105.77
-105.76
--
-105.77
FY 2021
0.00
--
--
--
--
137.99M
4.64M
133.19M
229.38K
--
-62.50K
--
-137.99M
7.74M
--
--
-130.25M
--
-130.25M
--
--
--
-130.25M
--
-130.25M
-53.60M
-183.85M
-183.85M
--
-183.85M
124.03K
-1482.26
-1482.28
--
-1482.77

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.